IndiaTickerAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Company dossier
Alivus Life Sciences
NSE:ALIVUS · ISIN INE03Q201024
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Alivus Life Sciences
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Trading Window - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Closure of Trading WindowBSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.BSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Outcome for Audited Financial Results And Recommendation Of Final DividendBSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Outcome of Board Meeting - Alivus Life Sciences LimitedNSE · financial results · pdf
Source filing Dividend - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing ESOP/ESOS/ESPS - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Press Release - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Investor Presentation - Alivus Life Sciences LimitedNSE · investor presentation · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Closure of Trading WindowBSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Considering And Approving Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026 And To Consider And Recommend Dividend, If Any, On Equity Shares For The Year Ended March 31, 2026.BSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Trading Window - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015BSE · exchange filing · pdf
Source filing General Updates - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing